Intelligence Platform

Patents

Browse 40 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 12370206

Therapy for inhibition of single-stranded RNA virus replication

RedHill Biopharma Ltd. · Granted Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12115150

Biomarkers of coronavirus pneumonia

RedHill Biopharma Ltd. · Granted Tue Oct 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11931463

All-in-one fixed-dose combination for treating Helicobacter pylori infection

RedHill Biopharma Ltd. · Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11918560

Serine protease inhibitor for treating coronavirus infection

RedHill Biopharma Ltd. · Granted Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11878011

Method for eradicating Helicobacter pylori infection in patients regardless of body mass i

RedHill Biopharma Ltd. · Granted Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11786541

Inhibitor of sphingosine kinase 2 for treating Ebola

RedHill Biopharma Ltd. · Granted Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11633385

Combination compositions for treatment of cancer

RedHill Biopharma Ltd. · Granted Tue Apr 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11590154

Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for t

RedHill Biopharma Ltd. · Granted Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11471448

Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe pat

RedHill Biopharma Ltd. · Granted Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11364227

Sphingosine kinase 2 inhibitor for treating coronavirus infection

RedHill Biopharma Ltd. · Granted Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11135172

Rifabutin-based compositions and methods for treating Helicobacter pylori infection

RedHill Biopharma Ltd. · Granted Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11090325

Compositions for treating ebola virus infection

RedHill Biopharma Ltd. · Granted Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11090326

Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimin

RedHill Biopharma Ltd. · Granted Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11058671

Formulations and methods of manufacturing formulations for use in colonic evacuation

RedHill Biopharma Ltd. · Granted Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11052073

Sphingosine kinase 2 inhibitor for treating coronavirus infection

RedHill Biopharma Ltd. · Granted Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11045453

Serine protease inhibitor for treating coronavirus infection

RedHill Biopharma Ltd. · Granted Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10946000

Method for treating cancer with combination therapy

RedHill Biopharma Ltd. · Granted Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10898439

Methods for treating helicobacter pylori infection

RedHill Biopharma Ltd. · Granted Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10765691

Method for treating crohn's disease using triple antimicrobial all-in-one formulation

RedHill Biopharma Ltd. · Granted Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10668050

Compositions, methods and kits for treating diarrhea-predominant irritable bowel syndrome

RedHill Biopharma Ltd. · Granted Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10543222

Therapy for inhibition of single-stranded RNA virus replication

RedHill Biopharma Ltd. · Granted Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10493065

Formulations and methods of manufacturing formulations for use in colonic evacuation

RedHill Biopharma Ltd. · Granted Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10463654

Combination therapies for treating cancer

RedHill Biopharma Ltd. · Granted Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10434114

Methods of treating a bacterial infection using a fixed-dose pharmaceutical composition co

RedHill Biopharma Ltd. · Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted